This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Natsuko Suginobe: Innovator in Vaccine Adjuvants
Introduction: Natsuko Suginobe is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of vaccine development, particularly in the area of cancer vaccines. Her innovative work has led to the creation of a unique compound that serves as a vaccine adjuvant.
Latest Patents: Natsuko Suginobe holds 1 patent for her invention titled "Water soluble adjuvant and composition containing same." This patent relates to a compound that is useful as a vaccine adjuvant for cancer vaccines. The invention includes a preparation process, a pharmaceutical composition comprising the compound, and its application as a vaccine adjuvant.
Career Highlights: Natsuko Suginobe is currently employed at Sumitomo Pharma Co., Ltd., where she continues to advance her research in pharmaceutical sciences. Her work is pivotal in enhancing the efficacy of cancer vaccines, which can lead to improved treatment options for patients.
Collaborations: Natsuko collaborates with esteemed colleagues, including Hitoshi Ban and Yosuke Takanashi. Their combined expertise contributes to the innovative research and development efforts at their company.
Conclusion: Natsuko Suginobe's contributions to vaccine adjuvants represent a significant advancement in cancer treatment. Her dedication to research and innovation continues to impact the pharmaceutical industry positively.